Literature DB >> 19818303

Histopathology of non-alcoholic fatty liver disease.

Elizabeth M Brunt1.   

Abstract

Current imaging methodologies can detect steatosis with increasing accuracy but cannot detect inflammation or pre-cirrhotic fibrosis or remodeling of the liver parenchyma. Imaging also cannot assess types or localization of hepatic steatosis. With the increased use of rodents to study NAFLD/NASH, careful analysis or reading highlights the fact that liver tissue evaluations reported in many of the popular animal models of NAFLD/NASH often do not imitate many of the significant aspects of the human disease, despite similar terminology applied by investigators. This review will focus on the findings in human disease.

Entities:  

Mesh:

Year:  2009        PMID: 19818303     DOI: 10.1016/j.cld.2009.07.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  38 in total

1.  Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Oguzhan Ozturk; Yasar Colak; Ebubekir Senates; Yusuf Yilmaz; Celal Ulasoglu; Levent Doganay; Seyma Ozkanli; Yasemin Musteri Oltulu; Ender Coskunpinar; Ilyas Tuncer
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

3.  The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.

Authors:  Sylvie Naveau; Karima Lamouri; Guillaume Pourcher; Micheline Njiké-Nakseu; Stefano Ferretti; Rodi Courie; Hadrien Tranchart; Mariana Ghinoiu; Axel Balian; Sophie Prévot; Gabriel Perlemuter; Ibrahim Dagher
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

Review 4.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

5.  How liver pathologies contribute to T1rho contrast require more careful studies.

Authors:  Yì Xiáng J Wáng; Weitian Chen; Min Deng
Journal:  Quant Imaging Med Surg       Date:  2017-10

Review 6.  The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease.

Authors:  Sven M Francque
Journal:  Eur Cardiol       Date:  2014-07

7.  Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Min Zeng; Yi Gao; Jun Weng
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

8.  Predictors of nonalcoholic steatohepatitis in obese children.

Authors:  Stacee Marie Lerret; Laura Garcia-Rodriguez; Joseph Skelton; Vincent Biank; Denise Kilway; Grzegorz Telega
Journal:  Gastroenterol Nurs       Date:  2011 Nov-Dec       Impact factor: 0.978

Review 9.  Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.

Authors:  David E Kleiner; Hala R Makhlouf
Journal:  Clin Liver Dis       Date:  2015-12-28       Impact factor: 6.126

Review 10.  Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.

Authors:  Chai Siah Ku; Yue Yang; Youngki Park; Jiyoung Lee
Journal:  J Med Food       Date:  2013-02       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.